Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 4
1953 4
1954 5
1955 5
1956 4
1957 2
1958 3
1959 3
1960 5
1961 7
1962 15
1963 13
1964 15
1965 11
1966 9
1967 19
1968 13
1969 17
1970 20
1971 20
1972 33
1973 17
1974 41
1975 38
1976 42
1977 49
1978 55
1979 54
1980 53
1981 69
1982 88
1983 98
1984 120
1985 114
1986 107
1987 98
1988 122
1989 117
1990 93
1991 108
1992 119
1993 122
1994 126
1995 155
1996 144
1997 212
1998 166
1999 207
2000 213
2001 206
2002 223
2003 197
2004 238
2005 250
2006 259
2007 246
2008 270
2009 274
2010 268
2011 301
2012 358
2013 343
2014 369
2015 411
2016 400
2017 431
2018 395
2019 383
2020 477
2021 578
2022 518
2023 455
2024 191

Text availability

Article attribute

Article type

Publication date

Search Results

10,297 results

Results by year

Filters applied: . Clear all
Page 1
Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis.
Takano S, Tomita N, Kuno M, Niwa M, Torii A, Takaoka T, Kita N, Okazaki D, Yamamoto S, Kawai T, Sugie C, Ogawa Y, Matsumoto K, Uchiyama K, Otsuka S, Matsui T, Miyakawa A, Mizuno T, Iida M, Tanikawa M, Mase M, Hiwatashi A. Takano S, et al. Among authors: yamamoto s. Sci Rep. 2024 Apr 23;14(1):9283. doi: 10.1038/s41598-024-60154-y. Sci Rep. 2024. PMID: 38654028
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Among authors: yamamoto s. Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18013. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38651779
Stress responses to bacterial and viral mimetics in polycystic ovary syndrome model rats.
Kamada S, Noguchi H, Yamamoto S, Tamura K, Aoki H, Takeda A, Uchishiba M, Minato S, Arata M, Arakaki R, Inui H, Kagawa T, Kawakita T, Yoshida A, Mineda A, Yamamoto Y, Kinouchi R, Yoshida K, Kaji T, Nishimura M, Iwasa T. Kamada S, et al. Among authors: yamamoto s. Brain Behav Immun Health. 2024 Apr 9;38:100772. doi: 10.1016/j.bbih.2024.100772. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38650845 Free PMC article.
Role of the medial agranular cortex in unilateral spatial neglect.
Ishii D, Osaki H, Yozu A, Yamamoto T, Yamamoto S, Miyata M, Kohno Y. Ishii D, et al. Among authors: yamamoto s. Exp Brain Res. 2024 Apr 22. doi: 10.1007/s00221-024-06817-8. Online ahead of print. Exp Brain Res. 2024. PMID: 38647701
Recombinant mycobacterial DNA-binding protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vaccinated individuals' blood cells in combination with CpG-DNA.
Ozeki Y, Yokoyama A, Nishiyama A, Yoshida Y, Ohara Y, Mashima T, Tomiyama C, Shaban AK, Takeishi A, Osada-Oka M, Yamaguchi T, Tateishi Y, Maeyama JI, Hakamata M, Moro H, Kikuchi T, Hayashi D, Suzuki F, Yamamoto T, Iho S, Katahira M, Yamamoto S, Matsumoto S. Ozeki Y, et al. Among authors: yamamoto s. Sci Rep. 2024 Apr 21;14(1):9141. doi: 10.1038/s41598-024-58836-8. Sci Rep. 2024. PMID: 38644371 Free PMC article.
Kisspeptin administration may promote precopulatory behavior in male rats independently or supplementally to testosterone and contribute to proceptive behavior in female partners, reducing mating failure.
Yamamoto S, Arakaki R, Noguchi H, Takeda A, Uchishiba M, Kamada S, Mineda A, Kon M, Kinouchi R, Yamamoto Y, Yoshida K, Kaji T, Shinohara N, Iwasa T. Yamamoto S, et al. Gen Comp Endocrinol. 2024 Apr 20;353:114528. doi: 10.1016/j.ygcen.2024.114528. Online ahead of print. Gen Comp Endocrinol. 2024. PMID: 38643848
Exogenous oxytocin increases gaze to humans in male cats.
Hattori M, Kinoshita K, Saito A, Yamamoto S. Hattori M, et al. Among authors: yamamoto s. Sci Rep. 2024 Apr 18;14(1):8953. doi: 10.1038/s41598-024-59161-w. Sci Rep. 2024. PMID: 38637547 Free PMC article.
Possibility of hypoalbuminemia itself as a risk for clinical failure.
Sumiyoshi S, Yamamoto S. Sumiyoshi S, et al. Among authors: yamamoto s. Antimicrob Agents Chemother. 2024 Apr 17:e0036724. doi: 10.1128/aac.00367-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 38629859 Free article. No abstract available.
Extracellular vesicles and prostate cancer management: a narrative review.
Urabe F, Yamada Y, Yamamoto S, Tsuzuki S, Kimura S, Ochiya T, Kimura T. Urabe F, et al. Among authors: yamamoto s. Transl Androl Urol. 2024 Mar 31;13(3):442-453. doi: 10.21037/tau-23-533. Epub 2024 Mar 20. Transl Androl Urol. 2024. PMID: 38590964 Free PMC article. Review.
Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.
Sakaguchi T, Mitsuke A, Osako Y, Yamada Y, Takeyama H, Ogawa R, Takahashi K, Hirohata Y, Yamamoto S, Arima J, Fukumoto W, Sugita S, Inoguchi S, Matsushita R, Yoshino H, Tatarano S, Enokida H. Sakaguchi T, et al. Among authors: yamamoto s. BMC Nephrol. 2024 Apr 8;25(1):124. doi: 10.1186/s12882-024-03561-7. BMC Nephrol. 2024. PMID: 38589827 Free PMC article.
Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections.
Kobayashi K, Takahashi S, Yasuda M, Miyazaki J, Wada K, Matsumoto M, Hayami H, Yamamoto S, Kiyota H, Sato J, Matsumoto T, Hasegawa N, Kobayashi I, Masumori N, Kimura T, Yamada H, Nakagawa T, Kaneko T, Matsumoto K, Fujimura T, Kamei J, Ishikawa K, Fujimoto K, Nakai Y, Shigemura K, Sadahira T, Hinata N, Kitano H, Yamashita M, Yasufuku T, Komeda H, Hiyama Y, Takahashi Y, Kanamaru S, Murakami M, Arakawa S, Yamada D, Mita K, Hamasuna R, Tanaka K, Matsukawa M, Takaoka E, Shigeta M, Takenaka T, Nishino M, Ishitoya S, Hayakawa S, Okumura K, Ueda M. Kobayashi K, et al. Among authors: yamamoto s. J Infect Chemother. 2024 Apr 6:S1341-321X(24)00108-9. doi: 10.1016/j.jiac.2024.03.024. Online ahead of print. J Infect Chemother. 2024. PMID: 38588797
Blood pressure classification using the Japanese Society of Hypertension Guidelines for the Management of Hypertension and cardiovascular events among young to middle-aged working adults.
Kuwahara K, Ohkubo T, Inoue Y, Honda T, Yamamoto S, Nakagawa T, Okazaki H, Yamamoto M, Miyamoto T, Gommori N, Kochi T, Ogasawara T, Yamamoto K, Konishi M, Kabe I, Dohi S, Mizoue T. Kuwahara K, et al. Among authors: yamamoto s. Hypertens Res. 2024 Apr 8. doi: 10.1038/s41440-024-01653-3. Online ahead of print. Hypertens Res. 2024. PMID: 38584158
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Nagasaka H, Kishida T, Kouro T, Igarashi Y, Takebe S, Yamamoto S, Kondo T, Koizumi M, Terao H, Suzuki T, Nakaigawa N, Himuro H, Wei F, Sasada T. Nagasaka H, et al. Among authors: yamamoto s. Int J Clin Oncol. 2024 Apr 6. doi: 10.1007/s10147-024-02477-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38580797
10,297 results
You have reached the last available page of results. Please see the User Guide for more information.